Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population

MLA

Naping Tang, et al. “Tissue Inhibitor of Metalloproteinase-2 G-418C Polymorphism Is Associated with an Increased Risk of Gastric Cancer in a Chinese Population.” European Journal of Surgical Oncology (EJSO), vol. 34, June 2008, pp. 636–41. EBSCOhost, https://doi.org/10.1016/j.ejso.2007.09.003.

APA

Naping Tang, Li Yang, Rihong Cong, Bo Zhou, Huai-Jun Zhu, Bin Wang, Haijuan Gu, & Qingmin Sun. (2008). Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population. European Journal of Surgical Oncology (EJSO), 34, 636–641. https://doi.org/10.1016/j.ejso.2007.09.003

Chicago

Naping Tang, Li Yang, Rihong Cong, Bo Zhou, Huai-Jun Zhu, Bin Wang, Haijuan Gu, and Qingmin Sun. 2008. “Tissue Inhibitor of Metalloproteinase-2 G-418C Polymorphism Is Associated with an Increased Risk of Gastric Cancer in a Chinese Population.” European Journal of Surgical Oncology (EJSO) 34 (June): 636–41. doi:10.1016/j.ejso.2007.09.003.